Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1081Question →

During a routine prenatal visit at 24 weeks gestation, a primigravid patient is advised to receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine, as well as the seasonal influenza vaccine. The patient immediately declines, stating, 'I have been meticulously following a natural, organic lifestyle to ensure my baby is healthy. I refuse to introduce any artificial chemicals or preservatives into my body right now.' Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: I understand you are dedicated to providing the best environment for your baby. Can you tell me more about your specific worries regarding these immunizations?

Answer

The most appropriate response is to validate the patient's goal of keeping her baby healthy and ask an open-ended question to explore her specific concerns about the immunizations.
The correct answer utilizes optimal patient-centered communication by first validating the patient's underlying positive intention (keeping her baby healthy) and then using an open-ended question to explore her specific beliefs. This approach builds a therapeutic alliance, prevents the patient from becoming defensive, and provides the physician with the necessary context to offer targeted, respectful education later in the encounter. Effective counseling requires understanding the patient's perspective before attempting to change it.

Step-by-Step Solution

1
Identify the primary clinical challenge presented in the vignette.
The patient is exhibiting vaccine hesitancy based on a preference for a 'natural' lifestyle and fear of 'chemicals'.
Recognizing the root of the patient's reluctance dictates the appropriate communication strategy.
2
Determine the most effective communication technique for a patient resisting a medical recommendation.
The physician must first build rapport and understand the patient's framework before offering medical facts.
Confrontation, fear-mongering, or citing authority usually entrenches the patient's defensive position.
3
Select the option that applies patient-centered interviewing skills.
The option that begins with empathy/validation ('I understand you are dedicated...') followed by an open-ended exploration ('Can you tell me more...') is the correct choice.
This aligns with the principles of motivational interviewing and effective health education.

Key Concept

Patient-centered communication and addressing vaccine hesitancy.
Question 1082Question →

Match each patient scenario describing a specific barrier to medication adherence with the most appropriate physician counseling strategy or intervention.

Click a left item, then click its matching right item

Items

A 55-year-old with hypertension reports only taking amlodipine when experiencing headaches, believing high blood pressure always causes physical symptoms.
A 72-year-old with heart failure is unable to explain the dosing schedule for their new medications after reviewing the written discharge summary.
A 48-year-old with type 2 diabetes frequently misses their midday metformin dose because they are busy at work and forget to bring the medication with them.
A 35-year-old with persistent asthma stops using their prescribed inhaled corticosteroid due to anxiety about potential systemic side effects like osteoporosis.

Matches

Show answer & explanation

Answer

The correct pairings match the specific barrier to medication adherence with the appropriate targeted intervention: the asymptomatic hypertension patient needs disease education; the confused heart failure patient needs the teach-back method; the busy diabetic patient needs regimen simplification; and the anxious asthmatic patient needs exploration of specific medication fears.
Each barrier to adherence requires a tailored counseling approach. Health belief deficits regarding asymptomatic diseases require direct education about long-term end-organ damage. Low health literacy is best addressed using the teach-back method rather than relying solely on written materials. Regimen complexity is best managed by simplifying dosing schedules. Intentional non-adherence due to medication fears requires non-judgmental exploration of those specific concerns before providing targeted reassurance.

Step-by-Step Solution

1
Analyze the hypertensive patient's scenario.
Identified a health belief deficit regarding asymptomatic disease.
To select the targeted education strategy explaining silent end-organ damage.
2
Analyze the heart failure patient's scenario.
Identified low health literacy and comprehension issues with standard paperwork.
To select the teach-back method as the necessary interactive communication tool.
3
Analyze the diabetic patient's scenario.
Identified logistical challenges associated with multiple daily doses.
To recognize that simplifying the medication to once-daily dosing is the most practical solution.
4
Analyze the asthmatic patient's scenario.
Identified intentional non-adherence due to fear of side effects.
To choose an approach that non-judgmentally elicits and addresses specific medication fears.

Key Concept

Tailoring patient counseling and interventions to the specific underlying cause of medication non-adherence.
Question 1083Question →

A 3434-year-old male with untreated HIV infection is hospitalized for progressive headache, fever, and confusion. Lumbar puncture reveals an opening pressure of 320 mm H2O320\text{ mm H}_2\text{O}, and cerebrospinal fluid analysis is positive for cryptococcal antigen with encapsulated yeast on India ink stain. He is started on appropriate intravenous induction antifungal therapy. Arrange the following critical steps in his longitudinal management and monitoring in the correct chronological sequence, from initial acute management to long-term ambulatory care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence spans from acute symptom control to long-term prophylactic discontinuation: serial therapeutic lumbar punctures (acute induction), transition to consolidation therapy (week 22), initiation of ART (weeks 44-66), reduction to maintenance therapy (week 1010), and discontinuation of secondary prophylaxis (>11 year).
Cryptococcal meningitis requires a highly algorithmic longitudinal approach to monitoring and treatment evaluation. Management begins with a 22-week induction phase (amphotericin B and flucytosine) where controlling elevated intracranial pressure via therapeutic lumbar punctures is the primary life-saving monitoring intervention. Once the cerebrospinal fluid is sterilized, therapy de-escalates to an 88-week consolidation phase with high-dose fluconazole. The most critical sequencing step is the initiation of antiretroviral therapy (ART); unlike most opportunistic infections, ART must be delayed until 44 to 66 weeks after starting antifungals to minimize the risk of fatal central nervous system immune reconstitution inflammatory syndrome (IRIS). Following consolidation, therapy steps down to a low-dose maintenance phase. Finally, this secondary prophylaxis is safely discontinued only when the patient has received at least 11 year of total antifungal therapy and demonstrates sustained immune recovery (CD4 >100 cells/mm3> 100\text{ cells/mm}^3 for at least 33 months).

Step-by-Step Solution

1
Identify the acute life-threatening complication requiring immediate mechanical intervention.
Elevated intracranial pressure (320 mm H2O320\text{ mm H}_2\text{O}) mandates serial therapeutic lumbar punctures during the initial induction phase.
Antifungal therapy alone does not rapidly lower ICP, which is a major cause of early mortality.
2
Determine the first pharmacological de-escalation milestone.
Transition to high-dose consolidation fluconazole.
This occurs at 22 weeks after cerebrospinal fluid cultures convert to negative, marking the end of induction.
3
Determine the optimal timing for immune restoration.
Initiate antiretroviral therapy (ART).
ART is delayed to 44-66 weeks to prevent severe central nervous system immune reconstitution inflammatory syndrome, placing this step squarely in the middle of the consolidation phase.
4
Identify the end of the active treatment phase.
Reduce to maintenance-dose fluconazole.
Consolidation lasts 88 weeks, so maintenance begins at week 1010 for long-term suppression.
5
Establish the criteria for definitive cessation of care.
Discontinue maintenance fluconazole.
Requires at least 11 year of treatment plus robust immune recovery (CD4 >100 cells/mm3> 100\text{ cells/mm}^3 for 33 months).

Key Concept

The precise chronological staging of cryptococcal meningitis treatment, characterized by sequential antifungal de-escalation and the critical delay of ART initiation to prevent paradoxical immune reactions.
Question 1084Question →

A 42-year-old biological female presents to the ambulatory clinic for a routine health maintenance examination. She was diagnosed with rheumatoid arthritis five years ago, which is currently well controlled on a regimen of adalimumab and low-dose methotrexate. Her surgical history includes a total abdominal hysterectomy for symptomatic uterine fibroids at age 38. She does not smoke or consume alcohol. Her body mass index is 24 kg/m2, and her blood pressure is 118/74 mmHg. A fasting lipid panel and fasting plasma glucose obtained last month were within normal limits.

Her vaccination records indicate she received an inactivated influenza vaccine one month ago and a tetanus, diphtheria, and acellular pertussis (Tdap) booster four years ago. She has never undergone a colonoscopy. Her most recent screening mammogram was performed eight months ago and showed benign findings.

Which of the following is the most appropriate preventive intervention for this patient at this time?

Show answer & explanation

Answer: Administration of a pneumococcal conjugate vaccine

Answer

Administration of a pneumococcal conjugate vaccine
The correct intervention is the administration of a pneumococcal conjugate vaccine. This patient is receiving immunosuppressive therapy (adalimumab and methotrexate) for rheumatoid arthritis. The Advisory Committee on Immunization Practices (ACIP) strongly recommends pneumococcal vaccination for adults aged 19 to 64 years with immunocompromising conditions, which includes iatrogenic immunosuppression. Due to her medication regimen, she is at elevated risk for invasive pneumococcal disease and should receive a pneumococcal conjugate vaccine.

Step-by-Step Solution

1
Analyze the patient's medical history and current medication regimen.
The patient has rheumatoid arthritis treated with adalimumab (a TNF-alpha inhibitor) and methotrexate.
Identifying the use of these medications is critical to recognizing that the patient has an iatrogenic immunocompromising condition.
2
Evaluate the patient's age and vaccination status against ACIP guidelines for immunocompromised individuals.
Although she is 42 (below the routine age-based cutoff of 50 for pneumococcal vaccination), her immunosuppressive therapy mandates vaccination with a pneumococcal conjugate vaccine to prevent invasive disease.
Guidelines explicitly recommend pneumococcal vaccination for adults aged 19-64 with conditions causing altered immunocompetence, including immunosuppressive drug therapy.
3
Assess the appropriateness of the remaining preventive care options based on age, surgical history, and medication contraindications.
Colonoscopy is premature (starts at 45), bone density measurement is premature (starts at 65 without major steroid use), vaginal cytology is unnecessary (post-benign hysterectomy), and live vaccines (MMR) are contraindicated.
Systematically ruling out the distractors ensures that pneumococcal vaccination is the singular most appropriate next step.

Key Concept

Adults aged 19-64 with iatrogenic immunosuppression (e.g., TNF-alpha inhibitors, methotrexate) require vaccination against pneumococcal disease and must avoid all live-attenuated vaccines.
Question 1085Question →

An 81-year-old woman is evaluated in the inpatient palliative care unit. She was admitted four days ago for management of intractable bone pain secondary to metastatic breast cancer. Over the past 24 hours, her level of consciousness has progressively declined, and she is now unresponsive to verbal and tactile stimuli. Her temperature is 37.1°C (98.8°F), blood pressure is 82/40 mm Hg, heart rate is 112/min, and respiratory rate is 14/min with brief periods of apnea. The patient's breathing has become increasingly noisy, characterized by a loud, gurgling sound during both inspiration and expiration. Her daughter, who is the designated healthcare surrogate, is at the bedside and is visibly distressed. She tells the physician, "It sounds like she is choking to death. Please do something to help her." Auscultation of the neck reveals prominent transmitted upper airway noises, while the lung bases are clear to auscultation. The patient is currently receiving a continuous intravenous morphine infusion. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer sublingual glycopyrrolate

Answer

The most appropriate next step is to administer an anticholinergic medication such as sublingual glycopyrrolate.
This patient is exhibiting terminal respiratory secretions, commonly referred to as the 'death rattle'. This phenomenon occurs in the final hours to days of life when profound neurological depression leads to a loss of the swallowing and cough reflexes, causing normal salivary and bronchial secretions to pool in the oropharynx. While the sound is often highly distressing to family members, there is no evidence that it causes discomfort to the unresponsive patient. The most appropriate management involves a combination of non-pharmacological measures (such as gentle repositioning or elevating the head of the bed) and pharmacological interventions to reduce secretion production. Anticholinergic agents, such as sublingual glycopyrrolate, sublingual atropine, or transdermal scopolamine, are the treatments of choice. Glycopyrrolate is often preferred because it is a quaternary amine that does not cross the blood-brain barrier, thereby avoiding central anticholinergic side effects like paradoxical agitation.

Step-by-Step Solution

1
Identify the patient's clinical sign.
Loud, gurgling respirations in an unresponsive, actively dying patient indicate the presence of terminal respiratory secretions, colloquially known as the 'death rattle'.
Accurate identification prevents the misdiagnosis of conditions like pulmonary edema or respiratory failure requiring invasive intervention.
2
Determine the underlying pathophysiology of the symptom.
The symptom is caused by the pooling of salivary and oropharyngeal secretions due to a loss of the swallowing reflex as the patient approaches death.
Understanding that this is a natural dying process guides the clinician toward symptomatic, non-invasive management rather than curative or invasive measures.
3
Select the most appropriate pharmacological and non-pharmacological interventions.
Anticholinergic medications (e.g., glycopyrrolate, atropine drops, scopolamine) are selected to decrease secretion production, combined with gentle repositioning and thorough family education.
These steps maximize patient comfort and address surrogate distress without causing iatrogenic harm.

Key Concept

Terminal respiratory secretions ('death rattle') in actively dying patients should be managed with family reassurance, patient repositioning, and anticholinergic medications (e.g., glycopyrrolate, scopolamine) rather than invasive suctioning.
Estimated Time:1m 15s
Question 1086Question →

Match each clinical scenario with the most appropriate level of palliative or hospice care.

Click a left item, then click its matching right item

Items

A 62-year-old woman with metastatic breast cancer who wishes to remain at home; her pain is stable on an oral opioid regimen, and she needs intermittent nursing visits for monitoring.
A 78-year-old man with end-stage chronic obstructive pulmonary disease receiving home hospice whose primary caregiver is severely fatigued and needs a brief period of relief.
A 59-year-old man with terminal pancreatic cancer who develops acute, intractable agitated delirium at home that is unresponsive to aggressive adjustments of subcutaneous medications.
A 71-year-old woman with severe heart failure who desires to continue life-prolonging intravenous inotropic therapy but requires expert symptom management and goals-of-care coordination.

Matches

Show answer & explanation

Answer

The patient with stable symptoms at home matches Routine home hospice care. The patient whose caregiver needs a break matches Inpatient respite hospice care. The patient with an acute, intractable symptom crisis matches General inpatient hospice care. The patient continuing life-prolonging milrinone matches Palliative care consultation without hospice enrollment.
Each level of palliative and hospice care is designed for specific patient and family needs. Palliative care can be provided concurrently with active treatment. Routine home hospice is for stable patients at home. Respite care is strictly for temporary caregiver relief. General inpatient hospice is for acute symptom crises unmanageable at home.

Step-by-Step Solution

1
Evaluate the 71-year-old woman receiving milrinone.
She desires to continue life-prolonging therapy.
Hospice enrollment generally requires foregoing life-prolonging treatments; thus, she needs palliative care without hospice.
2
Evaluate the 59-year-old man with intractable delirium.
He requires inpatient-level symptom control.
General inpatient hospice care is designated specifically for acute symptom crises that are unmanageable at home.
3
Evaluate the 78-year-old man with a fatigued caregiver.
He needs temporary placement for caregiver relief.
Respite hospice care provides up to 5 days of inpatient care primarily to relieve exhausted caregivers.
4
Evaluate the 62-year-old woman with stable symptoms.
She can safely be managed at home.
Routine home hospice care supports patients in their residence when they have stable terminal symptoms.

Key Concept

Differentiating the Medicare hospice care levels (routine home, general inpatient, and respite) and distinguishing them from concurrent palliative care.
Question 1087Question →

A 71-year-old man with severe chronic obstructive pulmonary disease has been in the intensive care unit (ICU) for 12 days for management of severe community-acquired pneumonia and acute respiratory distress syndrome. He remains ventilator-dependent and has failed multiple spontaneous breathing trials. The critical care team determines that he is entering a state of chronic critical illness. Arrange the following steps in the most appropriate chronological order for transitioning this patient to a Long-Term Acute Care Hospital (LTACH).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first recognize the clinical need, confirm the goals of care with the family, ensure medical eligibility through hemodynamic stability, complete the administrative coordination, and finally conduct the clinical handoff.
The correct sequence ensures that ethical and clinical prerequisites are met before administrative actions are taken. Recognizing the need triggers the process. Discussing goals of care must immediately follow to ensure LTACH transfer is actually desired. Achieving hemodynamic stability is the clinical prerequisite for acceptance. Only then can case management secure a bed based on medical eligibility. Finally, the clinician handoff ensures a safe physical transfer.

Step-by-Step Solution

1
Recognize the clinical failure to wean from short-term mechanical ventilation.
The medical team identifies that the patient is entering chronic critical illness.
Clinical recognition of the trajectory is the requisite first step before any transition planning can begin.
2
Conduct a goals of care discussion with the surrogate decision-maker.
The family confirms the desire to pursue prolonged life-sustaining therapy.
Ethically and clinically, goals of care must dictate all subsequent interventions and disposition planning.
3
Wean the patient from continuous vasoactive infusions.
The patient achieves hemodynamic stability.
LTACHs require patients to be hemodynamically stable without the need for acute resuscitation protocols or continuous vasopressors.
4
Submit clinical documentation to case management for LTACH approval.
Insurance criteria are verified and an LTACH bed is secured.
Administrative and financial clearance is required once medical eligibility and patient consent are established.
5
Perform a comprehensive clinician-to-clinician handoff.
Continuity of care is maintained during the physical transfer to the LTACH.
A detailed handoff prevents medical errors and ensures the receiving facility understands the weaning parameters and active medical issues.

Key Concept

The safe and ethical transition of a chronically critically ill patient to an LTACH requires a stepwise approach: clinical recognition, alignment of goals of care, achievement of medical stability, administrative clearance, and clinical handoff.
Estimated Time:1m 30s
Question 1088Question →

A 74-year-old man with a history of chronic obstructive pulmonary disease (COPD), osteoarthritis, and benign prostatic hyperplasia is being prepared for discharge after a 6-day hospital stay for a severe COPD exacerbation. During his hospitalization, his medication regimen underwent several modifications, including a tapering course of systemic corticosteroids and adjustments to his maintenance inhaler therapy. He is now hemodynamically stable and ready to transition back to his home.

The discharging physician is initiating the medication reconciliation process to ensure a safe transition of care. Arrange the following steps of this process in the correct chronological sequence according to standard patient safety protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Compile the pre-admission list, Compare with inpatient orders, Identify and resolve discrepancies, Generate the discharge list, and Communicate the updated list.
Medication reconciliation is a critical safety practice during care setting transitions. According to national patient safety guidelines (such as those from the Joint Commission), the process must follow a standardized chronological sequence to prevent adverse drug events. First, a Best Possible Medication History (BPMH) is compiled to establish a baseline. Second, this baseline is compared against active inpatient orders. Third, the physician identifies and clinically resolves any discrepancies, deciding which home medications to restart and which hospital medications to stop. Fourth, the final discharge medication list and prescriptions are generated. Finally, the reconciled list is communicated to the patient, caregivers, and receiving providers to ensure a safe and informed transition.

Step-by-Step Solution

1
Determine the initial step of the medication reconciliation process.
Compile the pre-admission medication list.
Establishing the baseline (Best Possible Medication History) is the necessary foundation of the reconciliation process.
2
Determine the second step.
Compare the pre-admission list against current inpatient orders.
The baseline must be actively compared with the current hospital regimen to identify any changes made during the admission.
3
Determine the third step.
Identify and resolve any unintended discrepancies.
Clinical judgment must be applied to evaluate differences and make therapeutic decisions before finalizing any orders.
4
Determine the fourth step.
Generate the finalized discharge medication list.
Once discrepancies are resolved, the actual discharge prescriptions and comprehensive list can be safely generated.
5
Determine the final step.
Provide the updated list to the patient and communicate with the primary care provider.
The transition process concludes with patient education and proper clinical handoff to the next care setting.

Key Concept

Discharge Medication Reconciliation Sequence
Estimated Time:1m 30s
Question 1089Question →

A 68-year-old male with highly symptomatic paroxysmal atrial fibrillation is scheduled to begin amiodarone therapy for rhythm control. He has a history of hypertension, type 2 diabetes mellitus, and chronic kidney disease stage 3. His current medications include lisinopril, metformin, and apixaban. He has no history of pulmonary disease. Which of the following baseline laboratory or diagnostic parameters are essential to obtain prior to initiating amiodarone therapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Thyroid-stimulating hormone level; Hepatic transaminases

Answer

The essential baseline monitoring parameters prior to starting amiodarone are a thyroid-stimulating hormone (TSH) level and hepatic transaminases.
Amiodarone is a highly effective antiarrhythmic agent but is associated with significant long-term toxicities. Because it contains iodine and structurally resembles thyroid hormone, it frequently causes either hypothyroidism or hyperthyroidism; thus, a baseline thyroid-stimulating hormone (TSH) level is mandatory, along with ongoing monitoring. Additionally, amiodarone can cause hepatotoxicity ranging from asymptomatic elevated liver enzymes to severe cirrhosis. Baseline and periodic monitoring of hepatic transaminases is therefore an essential component of patient management when initiating this drug.

Step-by-Step Solution

1
Identify the primary pharmacological agent being initiated and its well-known toxicity profile.
The patient is starting amiodarone, a Class III antiarrhythmic known for multiorgan toxicity, including thyroid, liver, lung, and ocular effects.
Recognizing the adverse effect profile dictates the required baseline screening.
2
Determine the standard baseline testing recommended before starting this medication.
Standard baseline testing includes an ECG, thyroid function tests, liver function tests, and a chest radiograph (often with pulmonary function tests).
Establishing baseline values is critical to detect future organ dysfunction caused by the drug.
3
Evaluate the distractors related to the patient's current medication list, specifically apixaban.
Apixaban does not require routine coagulation monitoring or serum drug level measurements, despite a known pharmacokinetic interaction with amiodarone.
Direct oral anticoagulants have predictable pharmacokinetics and do not require the intensive monitoring seen with warfarin.

Key Concept

Amiodarone requires comprehensive baseline and ongoing monitoring, including thyroid function (TSH) and hepatic transaminases, due to its high risk of multiorgan toxicity.
Question 1090Question →

Discharge planning is underway for a 72-year-old man who has been hospitalized for 8 days due to acute lower extremity weakness and severe back pain. Magnetic resonance imaging of the spine revealed a pathological fracture at T10 causing spinal cord compression. A subsequent biopsy confirmed metastatic non-small cell lung cancer. The patient underwent palliative radiotherapy and completed a course of high-dose dexamethasone.

Currently, the patient has irreversible paraplegia with absent sensation below the umbilicus. He requires a chronic indwelling urinary catheter. He is hemodynamically stable, and his pain is well-controlled on a scheduled oral morphine regimen. He requires total physical assistance for all activities of daily living, including feeding, bathing, turning in bed, and transferring to a chair.

The patient is fully alert and possesses intact decision-making capacity. Following an extensive multidisciplinary meeting, the patient and his wife express a strong desire to pursue a comfort-focused approach emphasizing quality of life, and they agree to hospice care. His oncologist estimates his life expectancy to be 2 to 3 months.

The patient resides in a single-story home with his 73-year-old wife. His wife suffers from severe ischemic cardiomyopathy, relies on a motorized wheelchair for mobility, and requires assistance from neighbors for household chores. They have no other family members living in the region.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility with concurrent hospice services

Answer

Transfer to a skilled nursing facility with concurrent hospice services
The correct answer is transferring the patient to a skilled nursing facility with concurrent hospice services. This patient has a terminal diagnosis with a prognosis of less than 6 months and explicitly desires a comfort-focused approach, making him an appropriate candidate for hospice. Determining the correct care setting requires evaluating both his symptom burden and his caregiving needs. Because his pain is well-controlled on an oral regimen, he qualifies for routine hospice care rather than acute inpatient hospice care. However, he is completely dependent for all activities of daily living, including turning in bed and transferring. His only available caregiver is his wife, who relies on a wheelchair and cannot physically provide the heavy manual labor required for his custodial care. Routine home hospice provides intermittent nursing and aide visits but does not supply 24-hour caregivers. Therefore, discharging him home is unsafe. A skilled nursing facility provides the necessary 24-hour room, board, and custodial assistance, while the partnered hospice agency simultaneously provides specialized end-of-life care.

Step-by-Step Solution

1
Assess the patient's clinical eligibility for hospice care.
The patient has a terminal illness with an estimated life expectancy of 2 to 3 months and desires comfort care, making him fully eligible for hospice services.
Establishing hospice eligibility determines the primary framework for the care transition.
2
Determine the appropriate level of hospice care based on symptom burden.
The patient's pain is well-controlled on an oral regimen, meaning he qualifies for routine hospice care rather than crisis-level care (General Inpatient or Continuous Home Care).
Hospice care is divided into specific levels; patients without acute, refractory symptoms do not meet criteria for inpatient or continuous crisis care.
3
Evaluate the patient's functional needs against the available home caregiving capacity.
The patient requires total physical assistance (custodial care). His only caregiver is wheelchair-bound and cannot safely provide this care, making the home environment unsafe for routine discharge.
Routine home hospice does not provide 24/7 physical caregivers. If the family cannot provide custodial care, an alternative facility-based setting must be utilized.
4
Select the care setting that bridges the gap between hospice needs and physical caregiving limitations.
A skilled nursing facility (SNF) is selected to provide 24-hour room, board, and custodial care, while the hospice agency provides routine end-of-life care on-site.
This combination ensures the patient receives safe, round-the-clock physical assistance while honoring his goals of care.

Key Concept

Determining the appropriate disposition for hospice-eligible patients requires synthesizing symptom severity (to choose the correct hospice level) with the functional capacity of available home caregivers.
Question 1091Question →

An ambulatory care physician is evaluating a 64-year-old man who presents for a chronic disease management visit. He has a 10-year history of type 2 diabetes mellitus and hypertension. His daily medication regimen includes lisinopril and insulin glargine, which was added four months ago due to suboptimal glycemic control. Today, laboratory results show a hemoglobin A1c of 9.8%, compared to 8.1% four months ago. His estimated glomerular filtration rate (eGFR) is 24 mL/min/1.73 m². The patient appears hesitant, looks down, and states, 'I know my numbers are probably bad. I try my best with the insulin, but it just doesn't happen every day.' Which of the following is the most appropriate next step in counseling this patient?

Show answer & explanation

Answer: Ask the patient to describe the specific challenges he faces with his insulin regimen.

Answer

Ask the patient to describe the specific challenges he faces with his insulin regimen.
When addressing medication non-adherence, the most effective initial communication strategy is to use open-ended, non-judgmental questions. This approach invites the patient to explain their specific barriers—which could include a fear of hypoglycemia, injection pain, financial constraints, or a misunderstanding of the regimen—without feeling accused or limited by the physician's assumptions. It establishes a therapeutic alliance and is a prerequisite to adjusting the treatment plan.

Step-by-Step Solution

1
Identify the primary clinical issue presented by the patient.
The patient is exhibiting medication non-adherence to his insulin regimen and is expressing hesitation and guilt about his poor glycemic control.
Recognizing the patient's emotional state and admission of non-adherence is the first step in formulating a supportive communication strategy.
2
Determine the optimal communication framework for addressing medication non-adherence.
The physician must use open-ended, non-judgmental questions to explore the underlying barriers to adherence.
Patients may omit medications for numerous reasons (e.g., fear of hypoglycemia, injection pain, cost, misunderstanding, or depression). Open-ended inquiry prevents the physician from making incorrect assumptions.
3
Evaluate and eliminate the alternative management choices.
Reject options that escalate therapy prematurely, jump to conclusions about the cause, or use contraindicated medications (e.g., metformin in a patient with an eGFR of 24 mL/min/1.73 m²).
Safe and effective patient management requires establishing the correct 'diagnosis' for the non-adherence before altering the treatment plan.

Key Concept

When addressing medication non-adherence, physicians should employ open-ended, non-judgmental inquiry to accurately identify patient-specific barriers before altering therapeutic regimens.
Question 1092Question →

Match each hospitalized patient's clinical presentation and functional status with the most appropriate post-acute care disposition.

Click a left item, then click its matching right item

Items

A 55-year-old recovering from an acute ischemic stroke with new hemiparesis. She is medically stable, cognitively intact, and demonstrates the stamina to actively participate in 3 to 4 hours of intensive, multidisciplinary physical, occupational, and speech therapy daily.
A 72-year-old recovering from a prolonged ICU course for severe acute respiratory distress syndrome. He is hemodynamically stable but remains dependent on a tracheostomy and mechanical ventilator, requiring a specialized, prolonged weaning protocol.
An 85-year-old recovering from severe sepsis complicated by profound deconditioning. He is medically stable but tires easily, tolerating a maximum of 30 to 45 minutes of physical therapy per day, and requires significant assistance with activities of daily living.
A 68-year-old who was admitted for acute osteomyelitis. He is now afebrile, medically stable, and independently ambulatory, but requires completion of a 6-week course of daily intravenous antibiotics.

Matches

Show answer & explanation

Answer

The correct pairings match each patient's medical complexity and rehabilitation tolerance to the specific admission criteria of post-acute care settings: Patient 1 matches to Inpatient Rehabilitation Facility (IRF); Patient 2 matches to Long-Term Acute Care Hospital (LTACH); Patient 3 matches to Skilled Nursing Facility (SNF); and Patient 4 matches to Home with Home Health Services.
Correct disposition requires matching patient characteristics to facility capabilities. IRFs require patients to tolerate intense therapy (minimum 3 hours/day). LTACHs serve patients with severe, complex medical conditions (e.g., prolonged mechanical ventilation) who no longer need ICU care. SNFs provide lower-intensity rehabilitation and skilled nursing for those who cannot tolerate an IRF. Home Health Services are ideal for patients who are functionally independent but require specific skilled interventions like intravenous antibiotics.

Step-by-Step Solution

1
Analyze the first patient's functional capacity and therapy needs.
The patient has a new neurologic deficit but can tolerate 3 to 4 hours of multidisciplinary therapy daily.
Identifying the patient's stamina (3+ hours/day) confirms eligibility for an Inpatient Rehabilitation Facility (IRF).
2
Evaluate the second patient's medical complexity.
The patient is hemodynamically stable but remains ventilator-dependent and requires a prolonged weaning protocol.
Patients requiring extended ventilator weaning or complex wound care who are too stable for the ICU but too complex for a standard ward or SNF belong in a Long-Term Acute Care Hospital (LTACH).
3
Assess the third patient's rehabilitation tolerance.
The patient is severely deconditioned and can only tolerate 30 to 45 minutes of physical therapy per day.
Patients who need rehabilitation but cannot meet the 3-hour daily minimum for an IRF should be placed in a Skilled Nursing Facility (SNF) for subacute, lower-intensity rehabilitation.
4
Determine the fourth patient's care requirements.
The patient is functionally independent and mobile but needs prolonged daily intravenous antibiotics.
When a patient has no ongoing skilled needs other than medication administration (e.g., IV antibiotics), Home with Home Health Services is the most appropriate and cost-effective disposition.

Key Concept

Appropriate disposition to post-acute care settings relies on synthesizing a patient's medical stability, specific nursing needs (e.g., ventilator weaning, IV antibiotics), and their physical tolerance for rehabilitation (e.g., ability to participate in 3 hours of daily therapy).
Question 1093Question →

Effective communication is a cornerstone of patient management and health education. Match each patient encounter scenario with the most appropriate initial physician communication statement or strategy.

Click a left item, then click its matching right item

Items

A patient with newly diagnosed metastatic colon cancer asks, 'Is this cancer going to kill me?' despite the family's explicit request to withhold the prognosis.
An elderly patient with multiple comorbidities is prescribed a new, complex regimen for heart failure and simply nods, stating, 'I understand the instructions perfectly.'
A patient becomes visibly angry and raises their voice regarding the two-hour delay in the waiting room before the clinic appointment.
A patient with severe alcohol use disorder states, 'I want to stop drinking, but I have failed rehab three times. I just do not have the willpower.'

Matches

Show answer & explanation

Answer

Match the ethical conflict regarding non-disclosure to assessing patient knowledge; the complex regimen to the teach-back method; the angry patient to emotional validation; and the discouraged patient with substance use disorder to affirmation.
Each matching pair represents a gold-standard communication technique tailored to a specific clinical barrier. Scenario 1 requires the 'Ask-Tell-Ask' framework to navigate family non-disclosure requests while respecting patient autonomy. Scenario 2 utilizes the 'teach-back' method, which is the most effective way to confirm health literacy and prevent medication errors. Scenario 3 relies on the NURS (Name, Understand, Respect, Support) model for empathetic communication, specifically validating the patient's frustration. Scenario 4 employs Affirmation (from the OARS core skills in motivational interviewing) to build self-efficacy in a discouraged patient.

Step-by-Step Solution

1
Analyze Scenario 1 (Family requests non-disclosure)
The physician must use the Ask-Tell-Ask framework to assess what the patient knows and wants to know before breaking bad news or bypassing the family's concerns.
Balances patient autonomy with sensitive, stepwise communication.
2
Analyze Scenario 2 (Complex regimen comprehension)
The physician must use the teach-back method to verify the patient's actual understanding.
Self-reported understanding frequently masks poor health literacy and leads to nonadherence.
3
Analyze Scenario 3 (Angry patient)
The physician should validate the patient's frustration and apologize for the systemic delay.
Naming and validating the emotion diffuses anger and preserves the physician-patient relationship.
4
Analyze Scenario 4 (Low willpower/relapse)
The physician should reframe the 'failures' as persistence and affirm the patient's resilience.
Affirmations build self-efficacy and support behavioral change in motivational interviewing.

Key Concept

Physician Communication and Patient Counseling Techniques
Question 1094Question →

A 68-year-old man is evaluated in the cardiology clinic. He has a history of rheumatic heart disease status post mechanical mitral valve replacement four years ago. He is maintained on warfarin, with a consistently stable INR between 2.5 and 3.5 over the past year. Today, his INR is 2.8. During the visit, the patient reports a 3-week history of episodic palpitations. An electrocardiogram obtained in the clinic confirms new-onset atrial fibrillation. To facilitate rhythm control, the cardiologist decides to initiate oral amiodarone. The patient's other daily medications include lisinopril and atorvastatin. Physical examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Show answer & explanation

Answer: Reduce the weekly warfarin dose by 25% to 50% and recheck the INR in 1 to 2 weeks

Answer

The most appropriate next step is to preemptively reduce the weekly warfarin dose by 25% to 50% and closely monitor the INR in 1 to 2 weeks.
The most appropriate next step in monitoring and treatment evaluation for this patient is to preemptively reduce the weekly warfarin dose by 25% to 50% and recheck the INR in 1 to 2 weeks. Amiodarone is a potent inhibitor of multiple cytochrome P450 enzymes, most notably CYP2C9. Warfarin exists as a racemic mixture, and its more pharmacologically active S-enantiomer is metabolized almost entirely by CYP2C9. When amiodarone is added to a stable warfarin regimen, it reliably decreases warfarin clearance, leading to elevated serum concentrations and a supratherapeutic INR. To prevent severe bleeding complications, clinical guidelines mandate an empiric reduction of the warfarin dose by 25% to 50% at the time amiodarone is initiated, followed by close laboratory monitoring as the new steady-state is achieved.

Step-by-Step Solution

1
Identify the patient's baseline status.
The patient has a mechanical mitral valve and is optimally anticoagulated with warfarin (INR 2.8, target 2.5-3.5).
Establishing the baseline helps determine if the current therapy is effective and guides the urgency of interventions.
2
Analyze the pharmacokinetic impact of the new medication.
Initiation of amiodarone will cause potent inhibition of CYP2C9.
CYP2C9 is the primary enzyme responsible for metabolizing the highly active S-enantiomer of warfarin.
3
Determine the clinical consequence of the drug interaction.
Without intervention, warfarin clearance will decrease, leading to an accumulation of the drug, a supratherapeutic INR, and a high risk of spontaneous hemorrhage.
Anticipating the interaction is necessary for preventive patient management.
4
Select the guideline-concordant monitoring and treatment adjustment.
Empirically reduce the maintenance warfarin dose by 25% to 50% upon starting amiodarone, followed by an INR check in 1 to 2 weeks.
This preemptive strategy safely maintains the INR within the therapeutic window during the transition phase.

Key Concept

When amiodarone is initiated in a patient stabilized on warfarin, the warfarin dose must be preemptively reduced by 25% to 50% due to amiodarone's potent inhibition of CYP2C9, which significantly decreases warfarin clearance.
Estimated Time:1m 15s
Question 1095Question →

A 58-year-old man with a history of alcohol-related cirrhosis is evaluated in the clinic for a follow-up visit. One week ago, he presented with tense ascites and newly developed bilateral 2+ pitting lower extremity edema. At that time, a sodium-restricted diet was reinforced, and he was prescribed spironolactone 100 mg100\text{ mg} and furosemide 40 mg40\text{ mg} daily. Today, the patient reports feeling generally well but notes increased thirst and a dry mouth. He denies abdominal pain, fever, confusion, or gastrointestinal bleeding. His weight has decreased by 7 kg7\text{ kg} (15.4 lbs15.4\text{ lbs}) since his visit one week ago. Blood pressure is 102/64 mmHg102/64\text{ mmHg} and pulse is 92/min92/\text{min}. Physical examination shows mild residual abdominal distention with a positive fluid wave, but his lower extremity edema has completely resolved.

Laboratory results obtained today are compared to those from one week ago:

Laboratory TestOne Week AgoToday
Sodium136 mEq/L136\text{ mEq/L}132 mEq/L132\text{ mEq/L}
Potassium4.2 mEq/L4.2\text{ mEq/L}4.8 mEq/L4.8\text{ mEq/L}
Blood urea nitrogen18 mg/dL18\text{ mg/dL}48 mg/dL48\text{ mg/dL}
Creatinine0.8 mg/dL0.8\text{ mg/dL}1.9 mg/dL1.9\text{ mg/dL}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue both spironolactone and furosemide

Answer

The most appropriate next step is to discontinue both spironolactone and furosemide.
This patient has developed a severe acute kidney injury (AKI) secondary to overly rapid diuresis. While a weight loss of 1 kg/day1\text{ kg/day} can be safe when peripheral edema is present, his edema has now completely resolved. Continued aggressive diuresis has mobilized fluid from the intravascular space, leading to hypovolemia, a markedly elevated blood urea nitrogen level, and a serum creatinine that has more than doubled from baseline. In a patient with decompensated cirrhosis, any significant AKI requires the immediate discontinuation of all diuretics (both spironolactone and furosemide) and any other nephrotoxic medications to restore renal perfusion and prevent the development of hepatorenal syndrome.

Step-by-Step Solution

1
Analyze the patient's clinical signs and weight trend.
The patient lost 7 kg7\text{ kg} in 77 days. While 1 kg/day1\text{ kg/day} is acceptable when peripheral edema is present, the edema has completely resolved, leading to intravascular volume contraction (evidenced by dry mouth and borderline blood pressure).
Tracking fluid compartments is essential in cirrhosis management to ensure diuresis targets extracellular fluid and not the intravascular space.
2
Interpret the comparative laboratory results.
The BUN has risen significantly, and the serum creatinine has more than doubled from 0.8 mg/dL0.8\text{ mg/dL} to 1.9 mg/dL1.9\text{ mg/dL}.
These findings confirm a diagnosis of prerenal acute kidney injury (AKI) secondary to aggressive diuresis.
3
Determine the necessary treatment modification based on the AKI diagnosis.
Both spironolactone and furosemide must be held immediately.
Continuing diuretics during an episode of AKI in a cirrhotic patient greatly increases the risk of progression to life-threatening hepatorenal syndrome.

Key Concept

Patients with cirrhosis and ascites who develop acute kidney injury (AKI) during diuresis must have all diuretic medications immediately discontinued to prevent progression to hepatorenal syndrome.
Question 1096Question →

A 4848-year-old woman comes to the clinic for a routine health maintenance examination. She feels well and has no specific complaints. Her past medical history is significant for a total abdominal hysterectomy for symptomatic benign uterine fibroids 44 years ago. She does not use tobacco, alcohol, or illicit drugs. Her family history is unremarkable. Her blood pressure is 118/76118/76 mm Hg, pulse is 7272/min, and BMI is 2424 kg/m 2^2. Her last screening mammogram was performed 1111 months ago and was normal. She has never undergone screening for colorectal cancer. Which of the following is the most appropriate next step in the preventive care of this patient?

Show answer & explanation

Answer: Referral for screening colonoscopy

Answer

Referral for screening colonoscopy is the most appropriate next step, as average-risk adults should begin colorectal cancer screening at age 45.
The correct answer is referral for screening colonoscopy. According to the United States Preventive Services Task Force (USPSTF), screening for colorectal cancer is recommended for all average-risk adults starting at age 45 and continuing until age 75. Because this patient is 48 years old and has never undergone screening, initiating colorectal cancer screening (via colonoscopy, fecal immunochemical testing, or another recommended modality) is the single most appropriate next step in her preventive care.

Step-by-Step Solution

1
Identify the patient's demographic risk profile and surgical history.
The patient is a 48-year-old female with no history of tobacco use and a past surgical history of a total hysterectomy for benign disease.
Age, sex, surgical history, and social habits dictate the indications for specific preventive screening tests.
2
Evaluate the patient's existing screening records against current guidelines.
She had a normal mammogram 11 months ago (due every 2 years). She had a total hysterectomy for benign fibroids (cervical cancer screening is no longer indicated).
To rule out interventions that are either premature or permanently contraindicated based on her medical history.
3
Identify missing age-appropriate screening interventions.
The patient has never been screened for colorectal cancer, which is universally recommended starting at age 45.
To select the single most appropriate and currently indicated preventive care step.

Key Concept

Average-risk colorectal cancer screening guidelines and indications for discontinuing cervical cancer screening.
Question 1097Question →

During a scheduled home hospice assessment, a 73-year-old man with metastatic pancreatic adenocarcinoma is found to be acutely confused and highly agitated. According to his spouse, the behavioral changes started abruptly 36 hours ago. The patient has been picking continuously at his bedsheets, experiencing visual hallucinations, and groaning loudly. His baseline pain regimen consists of a transdermal fentanyl patch and scheduled oral morphine, alongside daily oral senna. Prior to this episode, his pain was reported as well-controlled and he was resting comfortably. On examination, the patient is restless and disoriented to time, place, and person. Vital signs are within normal limits for his condition. Abdominal examination reveals a firm, distended midline mass extending just below the umbilicus; the patient grimaces when this specific area is gently palpated. Bowel sounds are normoactive in all four quadrants. Review of his daily symptom log indicates he has not voided urine or had a bowel movement in the past two days. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Insert an indwelling urethral catheter

Answer

Insert an indwelling urethral catheter to decompress the bladder and resolve the underlying cause of the agitation.
The correct response addresses the direct, reversible cause of this patient's hyperactive delirium. Acute urinary retention is a frequent complication in patients receiving scheduled opioids and anticholinergic medications. It presents as severe agitation, confusion, and abdominal discomfort. The physical examination finding of a firm, tender midline mass extending below the umbilicus is the classic presentation of a massively distended bladder. In palliative and end-of-life care, the standard protocol for sudden delirium is to first assess for and treat easily reversible causes (e.g., urinary retention, fecal impaction, hypoxia) before resorting to antipsychotics. Inserting an indwelling urethral catheter will drain the bladder, instantly relieving the physical distress and subsequently resolving the secondary delirium.

Step-by-Step Solution

1
Analyze the patient's acute presentation.
The patient has new-onset hyperactive delirium (agitation, hallucinations, disorientation) over the past 36 hours.
Identifying the primary clinical syndrome is necessary to formulate a targeted differential diagnosis in a hospice setting.
2
Correlate physical examination findings with the patient's history.
The presence of a firm, tender midline mass below the umbilicus combined with two days of anuria strongly indicates acute urinary retention.
Physical examination often reveals the reversible etiology behind sudden behavioral changes in palliative patients.
3
Select the most appropriate, least invasive intervention to address the root cause.
Catheterizing the bladder will provide immediate relief of the retention.
In palliative care, identifying and reversing easily treatable causes of distress (like full bladders or impacted bowels) must precede the use of pharmacologic sedation.

Key Concept

Evaluation and management of reversible causes of delirium, such as urinary retention, must be prioritized before initiating antipsychotics or palliative sedation in hospice patients.
Question 1098Question →

A 24-year-old woman with type 1 diabetes mellitus is admitted to the intensive care unit with diabetic ketoacidosis. She is initiated on appropriate intravenous normal saline, potassium replacement, and a continuous regular insulin infusion. Her initial blood glucose is 550 mg/dL550 \text{ mg/dL} and anion gap is 24 mEq/L24 \text{ mEq/L}.

Arrange the following monitoring and therapeutic steps in the correct chronological sequence required to safely transition this patient off intravenous insulin.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence involves first adding dextrose when glucose falls to prevent hypoglycemia, followed by confirming anion gap closure. Once the gap is closed, subcutaneous insulin is administered, and finally, the IV insulin is discontinued after a 1-to-2-hour overlap.
The correct sequence prioritizes maintaining the insulin infusion to close the anion gap while managing the dropping glucose levels by adding dextrose. Once the gap closes, a safe transition requires overlapping the new subcutaneous insulin dose with the IV drip for 11 to 22 hours to prevent rebound ketoacidosis.

Step-by-Step Solution

1
Monitor hourly blood glucose and add 5%5\% dextrose to IV fluids when glucose reaches 200 mg/dL200 \text{ mg/dL}.
Prevents hypoglycemia while allowing insulin to continue.
Insulin infusion must be continued to clear ketones, even if blood glucose normalizes rapidly.
2
Monitor basic metabolic panel every 22 to 44 hours until the anion gap is ≤12 mEq/L\leq 12 \text{ mEq/L} and venous pH is >7.3> 7.3.
Confirms resolution of diabetic ketoacidosis.
Anion gap closure indicates that ketone production (lipolysis) has been successfully suppressed.
3
Administer subcutaneous basal insulin when the patient can tolerate oral intake.
Prepares the patient for removal of the IV insulin drip.
Subcutaneous long-acting insulin has a delayed onset of action and provides baseline coverage.
4
Stop the IV insulin infusion 11 to 22 hours after giving the subcutaneous dose.
Safely completes the transition to maintenance therapy.
Overlapping the two insulin routes prevents a sudden drop in insulin levels that could precipitate rebound DKA.

Key Concept

Resolution of DKA requires continuous insulin until the anion gap closes; dextrose is added to prevent hypoglycemia, and subcutaneous insulin must overlap with the IV infusion for 11 to 22 hours before discontinuation.
Question 1099Question →

A 42-year-old man presents to the primary care clinic for counseling regarding his alcohol use. He exhibits varying levels of insight and readiness to change over a series of visits. Based on the Transtheoretical Model of Change and the principles of Motivational Interviewing, match each of the patient's statements with the most appropriate and effective physician counseling response.

Click a left item, then click its matching right item

Items

"My wife is overreacting about my drinking. I only have a few drinks to unwind after a stressful day, which is completely normal for someone in my high-pressure profession."
"I see that my blood pressure is elevated and I know the alcohol isn't helping, but the idea of stopping completely just seems impossible right now with my current work stress."
"I poured out my liquor cabinet yesterday and I plan to start abstaining this weekend, though I am deeply worried about how I will handle the physical cravings."
"It has been six months since my last drink. I feel fantastic, but the upcoming holiday season and being around my family has me feeling very anxious."

Matches

Show answer & explanation

Answer

Match the Precontemplation statement to the request for permission to discuss health effects; the Contemplation statement to the reflection of ambivalence; the Preparation statement to medical action planning; and the Maintenance statement to relapse prevention strategizing.
Effective patient counseling for behavioral change requires matching the physician's intervention to the patient's readiness stage as defined by the Transtheoretical Model. For Precontemplation, physicians should build rapport and ask permission. For Contemplation, physicians should explore ambivalence and elicit change talk. For Preparation, physicians help formulate specific, safe action plans. For Maintenance, physicians focus on identifying high-risk triggers and preventing relapse.

Step-by-Step Solution

1
Analyze the first patient statement.
The patient denies having a problem and blames his wife, indicating the Precontemplation stage of change.
Identifying the stage of change dictates the counseling technique; precontemplative patients require rapport building and asking permission to share information, rather than direct advice.
2
Analyze the second patient statement.
The patient recognizes harm (elevated blood pressure) but feels unable to stop, indicating the Contemplation stage.
Contemplative patients have ambivalence; the physician must reflect both sides of the ambivalence to help the patient move toward a decision without creating resistance.
3
Analyze the third patient statement.
The patient has taken a preliminary step (pouring out liquor) and set a date, indicating the Preparation stage.
Patients in preparation need assistance with concrete planning and barrier mitigation, such as safely managing physical withdrawal.
4
Analyze the fourth patient statement.
The patient has been abstinent for six months but anticipates a high-risk situation, indicating the Maintenance stage.
Maintenance counseling focuses on relapse prevention, self-efficacy reinforcement, and coping skill development for specific triggers.

Key Concept

Applying the Transtheoretical Model of Change and Motivational Interviewing techniques in patient counseling.
Question 1100Question →

A 32-year-old woman is evaluated in the clinic for fatigue and pica. Laboratory studies confirm severe iron deficiency anemia with a hemoglobin of 8.28.2 g/dL and a ferritin of 66 ng/mL. The physician initiates treatment with daily oral ferrous sulfate. Arrange the following monitoring and treatment evaluation steps in the correct chronological sequence from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: evaluate reticulocyte count (peaks at 1-2 weeks), measure hemoglobin concentration (normalizes at 4-8 weeks), measure serum ferritin (normalizes 3-6 months after hemoglobin correction), and finally discontinue oral ferrous sulfate therapy.
Following the initiation of oral iron therapy for iron deficiency anemia, the body prioritizes the creation of new red blood cells to address the oxygen-carrying deficit. The very first measurable response is an increase in immature red blood cells (reticulocytes), which peaks at 1 to 2 weeks. Following this reticulocytosis, the overall hemoglobin level slowly rises and typically normalizes within 4 to 8 weeks. Once the functional anemia is completely corrected, continued iron absorption goes toward replenishing the body's depleted iron stores, a process reflected by rising serum ferritin. This repletion phase takes 3 to 6 months of continuous therapy. Therefore, ferritin is measured last to confirm stores are full, after which the iron therapy can be safely discontinued.

Step-by-Step Solution

1
Identify the immediate physiologic response to iron supplementation.
Reticulocytosis occurs first.
The bone marrow immediately uses the newly available iron to rapidly produce new red blood cells, leading to a reticulocyte peak in 7 to 10 days.
2
Determine when the mature red blood cell mass normalizes.
Hemoglobin normalizes next.
As reticulocytes mature and accumulate in the peripheral blood, the total hemoglobin concentration rises, typically normalizing within 4 to 8 weeks.
3
Establish when total body iron reserves are adequately rebuilt.
Ferritin normalizes last.
Only after the body's functional iron needs (hemoglobin) are met does it begin to store excess iron as ferritin. This repletion phase takes an additional 3 to 6 months of continuous therapy.
4
Determine the appropriate endpoint of treatment.
Discontinue iron therapy.
Therapy is considered complete and can be stopped only when both the active anemia is resolved and the iron stores are fully replenished.

Key Concept

Chronological sequence of laboratory monitoring and treatment endpoints in iron deficiency anemia
PreviousPage 55 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 55 | Examkin